Emcure Pharma Approves Merger Of Two Wholly-Owned Subsidiaries, Zuventus Healthcare And Emcutix Biopharmaceuticals
Mumbai: Emcure Pharmaceuticals Limited on Monday announced that its Board of Directors approved a Composite Scheme of Amalgamation for two wholly-owned subsidiaries, Zuventus Healthcare Limited and Emcutix Biopharmaceuticals Limited, with the parent company. Board Meeting Details The Board of Directors met on October 12, 2026, commencing at 9:45 a.m. (IST) and concluding at 10:10 a.m. (IST) to…
We haven't written up this one. Free Press Journal has the full story — the link below goes straight to it.
